Clinical Trial Update: Pharmacokinetic Study of Two HIV Protease Inhibitors in Patients [Phase 4]

View source ↗

Summary

Phase 4 pharmacokinetic study of two HIV protease inhibitors in HIV-infected patients was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: University of Oklahoma | Conditions: HIV Infection | Phase 4 | Status: TERMINATED